Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
26.97
-0.07 (-0.26%)
Jun 29, 2026, 2:16 PM EDT - Market open
Alto Neuroscience Employees
Alto Neuroscience had 68 employees as of December 31, 2025. The number of employees decreased by 8 or -10.53% compared to the previous year.
Employees
68
Change (1Y)
-8
Growth (1Y)
-10.53%
Revenue / Employee
n/a
Profits / Employee
-$1,092,735
Market Cap
946.48M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 68 | -8 | -10.53% |
| Dec 31, 2024 | 76 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 479 |
| Pharming Group | 407 |
| Kura Oncology | 260 |
| DBV Technologies | 161 |
| Alpha Tau Medical | 121 |
| Solid Biosciences | 121 |
| Janux Therapeutics | 108 |
| ORIC Pharmaceuticals | 104 |
ANRO News
- 13 days ago - Alto Neuroscience Transcript: 7th Annual HCW Neuro Perspectives Hybrid Conference - Transcripts
- 14 days ago - Alto Neuroscience highlights publication in Nature Medicine on Prime-Praxol - TheFly
- 14 days ago - Alto Neuroscience Highlights Nature Medicine Publication Demonstrating Significant Effects of Pramipexole on Anhedonia - Business Wire
- 14 days ago - Alto Neuroscience Slides: Corporate presentation - Filings
- 26 days ago - Alto Neuroscience Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - Alto Neuroscience appoints Miller to Board of Directors - TheFly
- 4 weeks ago - Alto Neuroscience Appoints Karuna Therapeutics Founder Andrew Miller, Ph.D. to Board of Directors - Business Wire
- 5 weeks ago - Alto Neuroscience price target lowered to $33 from $35 at BofA - TheFly